115 related articles for article (PubMed ID: 18347914)
1. The diversity of KIR gene in Chinese Northern Han population and the impact of donor KIR and patient HLA genotypes on outcome following HLA-identical sibling allogeneic hematopoietic stem cell transplantation for hematological malignancy in Chinese people.
Dou LP; Zheng H; Wang C; Liu JH; Sun JF; Jin HJ; Gao CJ; Yu L; Da WM
Int J Hematol; 2008 May; 87(4):422-433. PubMed ID: 18347914
[TBL] [Abstract][Full Text] [Related]
2. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.
Hsu KC; Keever-Taylor CA; Wilton A; Pinto C; Heller G; Arkun K; O'Reilly RJ; Horowitz MM; Dupont B
Blood; 2005 Jun; 105(12):4878-84. PubMed ID: 15731175
[TBL] [Abstract][Full Text] [Related]
3. Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies.
Stringaris K; Adams S; Uribe M; Eniafe R; Wu CO; Savani BN; Barrett AJ
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1257-64. PubMed ID: 20302958
[TBL] [Abstract][Full Text] [Related]
4. Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
Sobecks RM; Wang T; Askar M; Gallagher MM; Haagenson M; Spellman S; Fernandez-Vina M; Malmberg KJ; Müller C; Battiwalla M; Gajewski J; Verneris MR; Ringdén O; Marino S; Davies S; Dehn J; Bornhäuser M; Inamoto Y; Woolfrey A; Shaw P; Pollack M; Weisdorf D; Milller J; Hurley C; Lee SJ; Hsu K
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1589-96. PubMed ID: 25960307
[TBL] [Abstract][Full Text] [Related]
5. Donor
Schetelig J; Baldauf H; Heidenreich F; Hoogenboom JD; Spellman SR; Kulagin A; Schroeder T; Sengeloev H; Dreger P; Forcade E; Vydra J; Wagner-Drouet EM; Choi G; Paneesha S; Miranda NAA; Tanase A; de Wreede LC; Lange V; Schmidt AH; Sauter J; Fein JA; Bolon YT; He M; Marsh SGE; Gadalla SM; Paczesny S; Ruggeri A; Chabannon C; Fleischhauer K
Front Immunol; 2024; 15():1350470. PubMed ID: 38629074
[TBL] [Abstract][Full Text] [Related]
6. The Influence of KIR Gene Polymorphisms and KIR-ligand Binding on Outcomes in Hematologic Malignancies following Haploidentical Stem Cell Transplantation: A Comprehensive Review.
Bakhtiari T; Ahmadvand M; Salmaninejad A; Ghaderi A; Yaghmaie M; Sadeghi A; Mousavi SA; Rostami T; Ganjalikhani-Hakemi M
Curr Cancer Drug Targets; 2023; 23(11):868-878. PubMed ID: 37226789
[TBL] [Abstract][Full Text] [Related]
7. High-Resolution Analysis Identifies High Frequency of
Tao S; He Y; Kichula KM; Wang J; He J; Norman PJ; Zhu F
Front Immunol; 2021; 12():640334. PubMed ID: 33995358
[TBL] [Abstract][Full Text] [Related]
8. Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML.
Fein JA; Shouval R; Krieger E; Spellman SR; Wang T; Baldauf H; Fleischhauer K; Kröger N; Horowitz M; Maiers M; Miller JS; Mohty M; Nagler A; Weisdorf D; Malmberg KJ; Toor AA; Schetelig J; Romee R; Koreth J
Blood Adv; 2024 Feb; 8(3):581-590. PubMed ID: 38052043
[TBL] [Abstract][Full Text] [Related]
9. Increased donor inhibitory KIR are associated with reduced GVHD and improved survival following HLA-matched unrelated donor HCT in paediatric acute leukaemia.
Krieger E; Qayyum R; Toor A
Br J Haematol; 2024 May; 204(5):1935-1943. PubMed ID: 38442905
[TBL] [Abstract][Full Text] [Related]
10. Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation.
Dobbelstein C; Ahn KW; Haagenson M; Hale GA; van Rood JJ; Miklos D; Waller EK; Spellman SR; Fernandez-Vina M; Ganser A; Aljurf M; Bornhaeuser M; Gupta V; Marino SR; Pollack MS; Reddy V; Eder M; Lee SJ
Biol Blood Marrow Transplant; 2013 May; 19(5):741-5. PubMed ID: 23380341
[TBL] [Abstract][Full Text] [Related]
11. Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies.
Varbanova V; Naumova E; Mihaylova A
Cancer Immunol Immunother; 2016 Apr; 65(4):427-40. PubMed ID: 26874942
[TBL] [Abstract][Full Text] [Related]
12. [The Role of NK Cells in Allogeneic Hematopoietic Stem Cell Micro-Transplantation for Acute Myeloid leukemia].
Liu RY; Yu CL; Qiao JH; Cai B; Sun QY; Wang Y; Liu TQ; Jiang S; Zhang TY; Ai HS; Guo M; Hu KX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):546-555. PubMed ID: 38660865
[TBL] [Abstract][Full Text] [Related]
13. High-resolution KIR and HLA genotyping in three Chinese ethnic minorities reveals distinct origins.
Tao S; Norman PJ; You X; Kichula KM; Dong L; Chen N; He Y; Chen C; Zhang W; Zhu F
HLA; 2024 Apr; 103(4):e15482. PubMed ID: 38625090
[TBL] [Abstract][Full Text] [Related]
14. Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han.
Deng Z; Zhao J; Cai S; Qi Y; Yu Q; Martin MP; Gao X; Chen R; Zhuo J; Zhen J; Zhang M; Zhang G; He L; Zou H; Lu L; Zhu W; Hong W; Carrington M; Norman PJ
Front Immunol; 2019; 10():1646. PubMed ID: 31379844
[TBL] [Abstract][Full Text] [Related]
15. Donor KIR2DL1 Allelic Polymorphism Influences Posthematopoietic Progenitor Cell Transplantation Outcomes in the T Cell Depleted and Reduced Intensity Conditioning Setting.
Wright PA; van de Pasch LAL; Dignan FL; Kichula KM; Pollock NR; Norman PJ; Marchan E; Hill L; Vandelbosch S; Fullwood C; Sheldon S; Hampson L; Tholouli E; Poulton KV
Transplant Cell Ther; 2024 May; 30(5):488.e1-488.e15. PubMed ID: 38369017
[TBL] [Abstract][Full Text] [Related]
16. Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma.
Naumova E; Mihaylova A; Ivanova M; Mihailova S
Cancer Immunol Immunother; 2007 Jan; 56(1):95-100. PubMed ID: 16547704
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment in haematopoietic stem cell transplantation: histocompatibility.
Petersdorf EW
Best Pract Res Clin Haematol; 2007 Jun; 20(2):155-70. PubMed ID: 17448954
[TBL] [Abstract][Full Text] [Related]
18. Exceptional diversity of KIR and HLA class I in Egypt.
Montero-Martin G; Kichula KM; Misra MK; de Brito Vargas L; Marin WM; Hollenbach JA; Fernández-Viña MA; Elfishawi S; Norman PJ
HLA; 2024 Jan; 103(1):e15177. PubMed ID: 37528739
[TBL] [Abstract][Full Text] [Related]
19. Maternal natural killer cell immunoglobulin receptor genes and human leukocyte antigen-C ligands influence recurrent spontaneous abortion in the Han Chinese population.
Su N; Wang H; Zhang B; Kang Y; Guo Q; Xiao H; Yang H; Liao S
Exp Ther Med; 2018 Jan; 15(1):327-337. PubMed ID: 29387191
[TBL] [Abstract][Full Text] [Related]
20. Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens.
Fuchs KJ; van de Meent M; Honders MW; Khatri I; Kester MGD; Koster EAS; Koutsoumpli G; de Ru AH; van Bergen CAM; van Veelen PA; 't Hoen PAC; van Balen P; van den Akker EB; Veelken JH; Halkes CJM; Falkenburg JHF; Griffioen M
Blood; 2024 May; 143(18):1856-1872. PubMed ID: 38427583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
